Head-to-head · Cost-Efficiency Index
Medical Health Institute vs MyDrHank
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Medical Health Institute
Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front.
Visit Medical Health InstituteMyDrHank
Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.
Visit MyDrHankThe verdict
Medical Health Institute takes it, leading the Cost-Efficiency Index 68 to 65. Medical Health Institute is a multi-service telehealth provider (weight loss, testosterone therapy, peptide therapy) advertising GLP-1 weight loss 'starting at $100/mo' a figure the company itself footnotes as contingent. MyDrHank still earns a C — Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Medical Health Institute.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Medical Health Institute | MyDrHank |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 65/100 |
| Semaglutide / mo | $100/mo (all doses, compounded) | $249/mo oral, $259/mo injectable (yearly prepay: $171 / $178) |
| Tirzepatide / mo | Not disclosed | $349/mo month-to-month ($240/mo only on a year prepaid) |
| Semaglutide / yr (modeled) | $1,200 | $2,988 |
| Tirzepatide / yr (modeled) | — | $4,188 |
| Coverage | Coverage not published | Not published; program excludes KS, LA, MS, NM, ND, WV |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #125 | #130 |
Medical Health Institute
68/100Where the value is
- Advertises a competitively low $100/mo entry price for GLP-1 weight loss
- Offers multiple service lines (weight loss, TRT, peptide therapy) under one provider
- LegitScript and HIPAA-compliance badges both displayed on the homepage
The tradeoffs
- The $100/mo headline price carries the company's own asterisk — '*Based on pharmacy availability' — meaning it is explicitly not a guaranteed rate before intake
- No dose tier or even which drug (semaglutide vs. tirzepatide) the $100 figure applies to is disclosed anywhere public
MyDrHank
65/100Where the value is
- The price does not change as your dose is titrated up — its FAQ states it plainly ("The price stays the same at every dose — no surprise price increases"), and dose-indexed pricing is the single most common way a cheap first month becomes an expensive fourth one
- A genuine oral route on semaglutide: a daily tablet, including one compounded with low-dose ondansetron specifically to blunt the nausea that ends most GLP-1 courses early
- The entire price ladder is public — monthly, quarterly, 6-month and yearly, with the total for each term printed beside the per-month figure — before any quiz, intake or email capture
The tradeoffs
- EVERY price the site advertises is a twelve-month prepay rate, and not by accident: the price display is coded to return the cheapest term in the ladder, so "From $X/mo" is always the yearly figure. No page shows a month-to-month rate beside it
- What the twelve months actually cost, up front: oral semaglutide $2,057 to reach the advertised $171/mo, injectable semaglutide $2,140 to reach $178/mo, and tirzepatide $2,883 to reach $240/mo
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.